Vivan Developed Therapies
In-house therapies developed by Vivan Therapeutics.
Introducing Vipremett™, a novel treatment protocol for the treatment of KRAS+ colorectal, and pancreatic cancers.
Pharmaceutical treatment of KRAS-mutant cancers has proven elusive. Vipremett™ is a novel combination of drugs that is effective against cancers that exhibit a KRAS mutation.
A provisional patent application has been filed to protect any formulation and mode of delivery of Vipremett™.
For more information on Vipremett™ and how it can be incorporated into your practice or for out-licensing opportunities please contact us.